Search research articles
Contact Us
Filters
Showing results (211-220 of 223) with videos related to
Page
of 23
Sort By:
Microbial Pathogenesis
|
July 31, 2024
Isolation, identification, and pathogenicity of two novel goose astrovirus from goslings with severe gout in China
Pengju Xu, Xuying Wang, Jie Wang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 24, 2024
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects
Wei Wang, Shengnan Zhang, Changlin Dou, et al.
Elife
|
February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrhea
Jana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
International Journal of Biological Macromolecules
|
June 8, 2026
Injectable thermosensitive hydrogel embedding lignin-modified PLGA microspheres enables sustained lidocaine release and prolonged neuromodulation
Xiuyu Qi, Shu Yang, Zhou Xu, et al.
Cell
|
May 8, 2021
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
Chang Cui, Kasturi Chakraborty, Xu Anna Tang, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 1, 2023
"Dual Anta-Inhibitors" of the A<sub>2A</sub> Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
Andrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 12, 2025
A<sub>2A</sub> receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment
Akshaya Murugesan, Aleksei Smirnov, Anxo Vila Alonso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 5, 2021
Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study
Qi Jiang, Dingxin Qin, Ling Yang, et al.
Journal of the National Cancer Institute
|
September 12, 2014
Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation
Huijie Bian, Jia-Sheng Zheng, Gang Nan, et al.
Cell Reports
|
September 28, 2017
Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity
Brittney R Coats, Kelly Q Schoenfelt, Valéria C Barbosa-Lorenzi, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 223) with videos related to
Sort By:
Page
of 23
Microbial Pathogenesis
|
July 31, 2024
Isolation, identification, and pathogenicity of two novel goose astrovirus from goslings with severe gout in China
Pengju Xu, Xuying Wang, Jie Wang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 24, 2024
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects
Wei Wang, Shengnan Zhang, Changlin Dou, et al.
Elife
|
February 9, 2022
Ribonucleotide reductase, a novel drug target for gonorrhea
Jana Narasimhan, Suzanne Letinski, Stephen P Jung, et al.
International Journal of Biological Macromolecules
|
June 8, 2026
Injectable thermosensitive hydrogel embedding lignin-modified PLGA microspheres enables sustained lidocaine release and prolonged neuromodulation
Xiuyu Qi, Shu Yang, Zhou Xu, et al.
Cell
|
May 8, 2021
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
Chang Cui, Kasturi Chakraborty, Xu Anna Tang, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 1, 2023
"Dual Anta-Inhibitors" of the A<sub>2A</sub> Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
Andrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 12, 2025
A<sub>2A</sub> receptor antagonist 4-(2-((6-Amino-9-ethyl-8-(furan-2-yl)-9H-purin-2-yl)amino)ethyl)phenol, a promising adenosine derivative for glioblastoma treatment
Akshaya Murugesan, Aleksei Smirnov, Anxo Vila Alonso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 5, 2021
Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study
Qi Jiang, Dingxin Qin, Ling Yang, et al.
Journal of the National Cancer Institute
|
September 12, 2014
Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation
Huijie Bian, Jia-Sheng Zheng, Gang Nan, et al.
Cell Reports
|
September 28, 2017
Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity
Brittney R Coats, Kelly Q Schoenfelt, Valéria C Barbosa-Lorenzi, et al.
Page
of 23